RhumbLine Advisers
PROK icon

RhumbLine Advisers’s ProKidney PROK Stock Holding History

RhumbLine Advisers’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
+54,101
New +$99K ﹤0.01% 3498
2025
Q2 		– Sell
-83,369
Closed -$73K – 4232
2025
Q1 		$73K Buy
83,369
+2,868
+4% +$3.98K ﹤0.01% 3482
2024
Q4 		$136K Sell
80,501
-9,892
-11% -$17.8K ﹤0.01% 3376
2024
Q3 		$174K Buy
90,393
+14,203
+19% +$32.2K ﹤0.01% 3306
2024
Q2 		$187K Buy
76,190
+6,181
+9% +$16.6K ﹤0.01% 3262
2024
Q1 		$115K Buy
70,009
+801
+1% +$1.18K ﹤0.01% 3398
2023
Q4 		$123K Buy
69,208
+564
+0.8% +$1.21K ﹤0.01% 3380
2023
Q3 		$314K Sell
68,644
-8,779
-11% -$84K ﹤0.01% 2910
2023
Q2 		$866K Buy
+77,423
New +$824K ﹤0.01% 2373

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

RhumbLine Advisers's PROK Position: Q2 2026 in Review

RhumbLine Advisers opened a new position in ProKidney (PROK) in Q2 2026: 54,101 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #3498 among its holdings. This is a return to the name: RhumbLine Advisers previously reported a position in PROK as recently as Q1 2025.

RhumbLine Advisers first reported a position in PROK in Q2 2023 and has held it in 9 quarters since. The position peaked at $866K in Q2 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • RhumbLine Advisers held 54,101 shares of ProKidney worth $110K as of Q2 2026.
  • ProKidney was a new RhumbLine Advisers position in Q2 2026.
  • ProKidney made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3498 holding.
  • RhumbLine Advisers first reported a position in ProKidney in Q2 2023 and has held it in 9 quarters since.
  • RhumbLine Advisers's ProKidney position peaked at $866K in Q2 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.